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Abstract 
Studies of in vitro activity of synthetic peptides derived from the A-gliadin structure were carried out using assays based on cultures of 
foetal chick intestinal mucosa nd on incubation with rat liver lysosomes. The peptide corresponding toresidues 11-19, displayed very 
high activity in the chick intestinal assay, but was only weakly active in the lysosomal assay. Peptide 9-19 was highly active in the chick 
intestinal assay but was only mildly active in the lysosomal ssay. Peptide 8-19 was still appreciably active in both assays. The results on 
this group of peptides uggest he importance of residues 8-12 to activity and possibly also of a N-terminal glutamine residue. The 
peptide 213-227, found in a sub-fraction of fraction 9, was only weakly active in both assays, indicating that the PSQQ motif was not 
solely responsible for toxicity. Thus, as the peptide 208-219 was shown previously to be active in the chick intestinal assay, it is likely 
that the 208-212 region of this peptide is of prime importance in conferring activity. The results show, for the first time, that a 
nonapeptide from the N-terminal region of A-gliadin is very active in an in vitro model of toxicity in coeliac disease. 
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1. Introduction 
The bioactivity of gliadin-derived peptides in organ 
culture models of coeliac disease appears to be associated 
with certain key sequences of amino acids [1]. However, it 
is clear that the key sequences PSQQ and QQQP are not 
sufficient by themselves to cause toxicity [2,3]. Both de 
Ritis et al. [1] and Wieser et al. [4] have shown fragments 
from the first 55 amino acids to be toxic, but toxicity does 
not appear to be limited to regions near the N-terminus of 
A-gliadin. De Ritis et al. have also shown that a peptide 
from between 128 and 246 of A-gliadin is toxic in vitro 
[1]. The key sequences in this large region include only a 
single QQQP (188-191) and a PSQQ (213-216). 
Furthermore, we have shown recently [3] that a syn- 
thetic peptide corresponding to residues 75-86 of A-glia- 
din, matched to one isolated from fraction 9 [5], is toxic in 
two in vitro models of coeliac disease. This peptide con- 
tains the motif QQPY also found at residues 40-43 and 
52-55 of the A-gliadin molecule. It also contains the 
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sequence YPQPQ, which Graf et al. showed to be 
immunologically active as a pentapeptide [6]. 
In addition to the QQPY motif, the PSQQ motif also 
appears in three regions and is thought to be associated 
with toxicity. It forms part of Kocna's active peptide 8-19 
[2], in which PSQQ is combined with QQQP in a 6 amino 
acid sequence, PSQQQP. This latter peptide, however, is 
non-toxic [3]. Substitution of the QQQ in the active pep- 
tide 8-19 with AAA, NNN or PPP at positions 15-17 
produces non-toxic peptides. On the other hand, substitu- 
tion of P and S by T and G at positions 13 and 14 
respectively, did not reduce toxicity [2]. The toxicity of 
this peptide is therefore most likely to be due to the QQQP 
sequence. Wieser's active peptide, CT-1 (3-24) [4], also 
contains Kocna's active peptide. 
The PSQQ motif is also found between residues 50 and 
53 of the A-gliadin molecule. This motif, as well as the 
QQPY motif, is contained within Kocna's active peptide 
45-56 [2]. However, Peptide IV (46-57) [3] and Tron- 
cone's peptide 44-55 [7] are both inactive, suggesting that 
the PSQQ and QQPY motifs are by themselves not respon- 
sible for activity and that N-terminal and/or C-terminal 
amino acids are also involved. 
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The other egion containing the motif PSQQ is 213-216. 
This forms part of Kocna's active peptide 208-219 [2]. 
The peptide 209-222 was found to be non-active [8] by 
immunological assays, suggesting that it is because the 
methods of evaluation of activity are disparate or that other 
amino acids, such as the N-terminal or C-terminal glu- 
tamine residues are important to toxicity. 
It is interesting that, apart from PSQQ, this region 
contains the motif QQNP combined as PSQQNPQ. The 
QQNP motif is, of course, similar to the QQQP found at 
residues 15-18, 33-36, 188-191 of the A-gliadin se- 
quence. It would help to explain why Kocna's peptide 
208-219 [2] and peptide CNII (128-246) [1] are both 
toxic, although toxicity of the latter peptide could also be 
due to QQQP (188-191). 
This paper is an attempt o determine the in vitro 
activity of some serine-containing peptides and to ascertain 
the importance of the PSQQ motif in this activity. One of 
these peptides, PSQQNPQAQGSVQPQ, corresponding to
residues 213-227 of the A-gliadin structure, was shown to 
be present in a sub-fraction of fraction 9 which was active 
to lysosomes. The synthetic peptide is to be tested for 
activity in the lysosomal assay and in the foetal chick 
assay [3], so that further appraisals can be made of the 
influence of the PSQQ motif in biological activity. This 
will be helpful in assessing the significance of the C-termi- 
nal domain of A-gliadin in regard to toxicity in coeliac 
disease. At the same time, serine-containing peptides from 
the N-terminal region of the A-gliadin molecule will also 
be investigated because there is a need to determine the 
reason for the toxicity of peptide XT(1-30) [1], and in 
particular the peptide 8-19 [2], both of which include the 
PSQQ motif. 
2. Materials and methods 
2.2. Foetal chick intestinal test system 
Duodena of 12-day-old chicken embryos were prepared 
and cultured for 2 days as described previously [10] using 
a modified Minimal Essential Medium, free from serum 
and hormones. All the synthetic peptides and fraction 9 
(the positive control) were tested at a concentration f 0.5 
mg/ml of culture medium. Sucrase activity was deter- 
mined in the explants and the medium by a modification of 
the method of Dahlqvist as described previously [10]. The 
changes in sucrase activity in the explants and the medium 
during culture were expressed as percentages with respect 
to the control cultures (no added peptide). Activity after 
control culture was set to 100% and activity before culture 
was set at zero. There was already a small activity when 
the culture was started (after control culture the activity 
was 3-5 times higher than before culture). So the results 
are expressed as a percentage of the increase of activity 
during culture. A value lower than 100% but higher than 
0% means that the increase was diminished, but after 
culture there was still more activity than before. A nega- 
tive value means that the activity after culture was even 
below the starting value. This does not necessarily mean 
inhibition of enzyme activity if one considers that during 
culture new enzyme is synthesised and at the same time 
there is some degradation of sucrase. An absolute (com- 
plete) inhibition of increase in sucrase activity yields only 
zero percent if no steady degradation of the enzyme takes 
place. Because such a normal slow degradation of sucrase 
can easily be assumed, a very strong inhibition of sucrase 
synthesis could even lead to negative values. 
Protein content of the explants was estimated by the 
method of Lowry et al. [11] using bovine serum albumin as 
standard and expressed as percentages of control culture. 
Statistical differences were evaluated using the two-tailed 
Wilcoxon rank sum test for paired observations. 
2.1. Synthetic peptides and fraction 9 
Peptides VI and IX were prepared by CSIRO, Division 
of Biomolecular Engineering, Parkville, Australia, through 
the courtesy of Dr. D.E. Rivett. Peptides VII and VIII were 
supplied through Ms. D. Alewood, Drug Design and De- 
velopment Centre, University of Queensland, Queensland, 
Australia. The high purity of all peptides was confirmed by 
HPLC and their sequences are shown in Table 1. 
Fraction 9 was obtained by S.P. Sephadex chromatog- 
raphy of a peptic-tryptic-pancreatinic (PTP) digest of wheat 
gliadin (Capelle Despres, BDH, UK) as described previ- 
ously [9]. 
Peptic-tryptic digests of bovine serum albumin (Sigma, 
St. Louis, USA) and lactic 'vitamin-free' casein (Sigma, 
St. Louis, USA), prepared in the same manner as for the 
first two stages of the PTP gliadin digest [9], were also 
included for comparison (called P.T.B.S.A. and P.T. ca- 
sein, respectively). 
Table 1 
Sequences of  peptides evaluated with A-gl iadin sequences indicated by 
superscripts 
Peptide code Sequence* 
213 227 
Peptide VI PSQQNPQAQGSVQPQ 
11 19 
Peptide VII QNPSQQQPQ 
9 19 
Peptide VIII QPQNPSQQQPQ 
8 19 
Peptide IX LQPQNPSQQQPQ 
a Single letter codes are used for greater convenience. 
Amino acids referred to above are: P = Pro, S = Ser, Q = Gin, N =Asn,  
A = Ala, G = Gly, V = Val, L = Leu. 
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Table 2 
Effects of synthetic peptides and of fraction 9 on the increase of sucrase activity and protein content after culture of foetal chick intestine 
Peptide Sucrase (%) (mean + S.E. a) Protein (%) (mean + S.E.) No. of tubes 
in explants in medium in explants 
Peptide VI 88 _+ 12 95 +_ 14 
Peptide VII - 33 5= 6 * 17 _+ 4 * 
Peptide VIII - 6 + 14 * 56 + 14 * 
Peptide IX 60 _+ 12 * 74 _+ 3 * 
Fraction 9 32 +_ 13 * 36 _+ 6 * 
a Standard error of mean. 
• P < 0.05 according to 2-tailed Wilcoxon test. 
101 + 12 6 
52+6 * 8 
85 + 13 6 
86+6 8 
68+8 * 5 
2.3. Incubation with rat liver lysosomes 
Solutions of peptides and of fraction 9, each at a 
concentration of 6 mg/ml  in phosphate-buffered saline 
(PBS) (0.1 ml) were incubated with a suspension of rat 
liver lysosomes in 0.3 mol / l  sucrose solution (0.1 ml) for 
1 h at 37°C in the presence of trypsin inhibitor as de- 
scribed previously [12]. After incubation, 2.5 ml of PBS 
was added with mixing and the absorbance read at 405 nm. 
Al l  tests were done in quadruplicate. Zero-times (without 
fraction, before incubation) and controls (without fraction, 
after incubation) were also carried out. Activity was ex- 
pressed as the difference between the absorbance of the 
sample and that of the zero time, divided by the latter and 
calculated as a percentage [12]. Statistical validation was 
carried out using the Wilcoxon test and also Student's t
test. 
3. Results 
Table 2 shows the effects of the synthetic peptides and 
of fraction 9 on sucrase activity in the explants and 
medium during culture. Protein content of the explants is 
also shown. The results indicate activity in peptides VII, 
Table 3 
Effects of synthetic peptides and of fraction 9 on rat liver lysosomes 
Expt. Peptides Activity (%) 
No. (mean + S.E.) a 
1 Peptide VI 13.8 + 1.1 * * 
P.T. Casein 14.0 + 0.5 * * 
P.T.B.S.A. 12.1 + 1.3 * 
Fraction 9 43.1 + 1.3 * * * 
Controls 6.9 + 1.0 
2 Peptide VII 11.9+ 1.5 * 
Peptide VIII 1611 + 0.7 * * 
Peptide IX 22.0 + 1.3 * * * 
Fraction 9 44.1 + 0.7 * * * 
Controls 8.4 + 1.5 
a Means of 4 experiments. Student's t test for 2 small sets of observa- 
tions was applied: P<0.02 (*); P<0.01 (**); P<0.001 (***). 
Wilcoxon test is unable to differentiate between fractions as the test 
results are ranked higher than the controls, hence the probabilities are the 
same for all fractions (P < 0.015, one-tailed test). 
VIII and IX and in fraction 9. Thus, peptide VII (11-19), 
is more active than peptide VIII (9-19)  which is in turn 
more active than peptide IX (8-19).  A large decrease in 
sucrase activity below the starting value, such as was 
obtained with peptide VII indicates very high toxicity. 
Peptide VI (213-227) may be weakly active, but this is not 
significant at P < 0.05 level. The greatest changes are 
seen in the sucrase levels in the explants. 
Table 3 shows the results of the rat liver lysosomal 
assays. They indicate significant activity in peptide IX and 
fraction 9 with mild activity in peptides VI, VII and VIII. 
There was also only mild activity in the PT casein and PT 
BSA. 
4. Discussion 
The results of the assay using foetal chick intestine 
confirm the activity of peptide IX, a peptide corresponding 
to residues 8 -19  of the A-gliadin molecule, as reported 
previously [2]. Once again, it has been demonstrated that 
the activity of such peptides depends upon more than the 
key sequences of amino acids, such as PSQQ and QQQP, 
as proposed by de Ritis et al. [1]. Peptide IX contains the 
combined sequence PSQQQP, but the results of the present 
work show that the activity depends considerably on the 
amino acids of residues 8-12.  The PS is probably not 
important o activity as substitutions did not alter activity 
(refer to Table 4). Instead, the QPQN seems to be impor- 
tant. 
The most active peptide was peptide VII, corresponding 
to residues 11-19 of A-gliadin, thus indicating that QN 
causes greater enhancement of activity than QPQN. The 
results obtained indicated the highest activity of any pep- 
tide yet tested in this assay. It is the first time that sucrase 
levels have been reduced to below starting levels. This was 
especially true of peptide VII and to a lesser extent with 
peptide VIII (9-19).  The explanation probably lies in an 
even greater inhibition of biosynthesis of sucrase than we 
have noted previously with fraction 9 [3], together with the 
slow ongoing process of sucrase degradation. These as- 
pects are detailed in Section 2. It was significant that 
peptide VIII was also more active than peptide IX. These 
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two latter peptides differ only in that the N-terminal 
leucine of peptide IX has been removed, hence this leucine 
residue appears to diminish activity. The fact that both 
peptides VII and VIII have an N-terminal glutamine and 
are active suggests that this may be an important factor in 
the toxicity of certain gliadin peptides. If this is so, it 
would revive an old hypothesis by Messer et al. [13] who 
thought ring closure of N-glutaminyl peptides could be a 
possible mechanism explaining the detoxification of gluten 
by digestion with crude papain. 
It has been obvious from the high activity displayed by 
fraction 9 in the foetal chick intestinal assay, that other 
active peptides beside the major one (peptide V) [5] are 
present. Fraction 9 contains peptides larger than peptide 
VII, some of which may contain the sequence correspond- 
ing to residues 11-19 within their structure. Allowing for 
the presence of /3- and 3,-gliadin peptides, there are some 
sub-fractions of fraction 9 with similar amino acid compo- 
sition to the fragment 11-24 of A-gliadin. It was necessary 
to work with fraction 9 because it contains peptides of 
between 12 and 16 amino acid residues and it has been 
shown to be toxic in vivo [14]. 
A hexapeptide, (peptide I), corresponding to residues 
13-18, was reported in our previous paper as being inac- 
tive [3]. Hence, experiments now need to be carried out in 
order to ascertain which deletions cause a loss in activity. 
A puzzling aspect of the results of the present work is 
the lack of correlation between the results of the foetal 
chick assay and those of the lysosomal assay with peptides 
VII, VIII and IX. Until now, the correlation was good [3] 
and made this latter assay valuable for screening peptides 
because of the small amounts of sample required. The size 
of the peptide may be a factor and the fact that peptide VII 
is only a nonapeptide may mitigate against high activity in 
Table 4 
Summary of  activity of  peptides in the 8 -19  amino acid sequence of  the 
A-gl iadin molecule 
Peptide Position in A-gliadin Effect on sucrase 
designation in explants 
(%Xmean _+ SEM) 
8 9 t0 II 12 13 14 ['3 16 17 18 19 
Peptide VI L Q P Q N P S N N N _ P Q 107 ± 17 Ref I21 
PeptidelV L Q P Q N _T* 2 '  Q Q Q P Q 53:t:8. Ref[2] 
Pcptidc[ L Q P Q N P S Q Q Q P Q 59±18" Ref[2] 
Present P¢ptide IX L Q P Q N P S Q Q Q P Q 60 ± 12* 
paper 
present Pcptid¢ VIII Q P Q N P S Q Q Q P Q - 6 ± 14" 
paper 
Pcptide VII Q N P S Q Q Q P Q -33 ± 6* Present 
paper 
Peptide I P S Q Q Q P 107 ± 17 Ref [31 
Substitutions are underlined. 
T = Thr, G = Gly. 
* P = < 0.05 (Wilcoxon). 
the lysosomal assay. The role of lysosomal hydrolases i  
also an unknown factor. Although it is likely that some 
peptides are immunologically active whilst others are di- 
rectly toxic, this is an unlikely explanation, since both 
assays probably rely heavily on direct toxic action. How- 
ever, it must be stressed that cytotoxicity, as measured by 
action on lysosomes, is not specific for coeliac disease. 
Peptides active in the foetal chick intestinal assay seem 
to act on differentiation processes of the foetal duodenum. 
Such processes appear to include the biosynthesis of disac- 
charidases, ince the amounts of these enzymes produced 
by the tissue are curtailed by the presence of these peptides 
in the culture medium. 
A decrease below zero, as was observed with two of the 
peptides, means that the activity is reduced below the level 
which was already present at the beginning of culture. 
Thus, there appears to be strong inhibition of sucrase 
synthesis by peptide VII. 
The results of the foetal chick assay are in the process 
of being correlated with those of assays based on coeliac 
small intestinal mucosa. It is likely that in the latter assay, 
mechanisms of direct toxicity are involved, as well as to 
those mediated by certain cells of the immune system. In 
assays involving foetal tissue, the latter system is perhaps 
not involved to the same extent. It is vital that the peptide 
11-19 now be tested in vitro with coeliac mucosa. 
The peptide corresponding to residues 213-227 of A- 
gliadin (peptide VI) is only of very weak activity in both 
assays. This is another example of where the PSQQ by 
itself is not sufficient for activity and certain amino acids 
need to be present forming a larger peptide before activity 
is observed. It is difficult to explain the activity of the 
peptide 208-219 of Kocna et al. [2] in terms of any other 
known key sequences. It was thought that the motif QQNP, 
being similar to QQQP and combined with PSQQ as 
PSQQNP (like PSQQQP of peptide 13-18) could be im- 
portant. This may be so, but again, activity would be likely 
to depend upon all or part of residues 208-212, i.e., 
QGSFR, i.e., some N-terminal extension of the PSQQNP 
seems to be necessary for activity. In fact, Mantzaris and 
Jewell [15] have shown that the peptide 206-217 is active 
in vivo. It is not known how this activity compares with 
other similar peptides, because it was the only one tested 
in this way. This peptide contains a leucine residue at the 
N-terminus. However a peptide without this leucine, and 
perhaps even one with the next glycine residue deleted 
(208-217) may still be toxic, like 208-219. For that 
matter both could be even more toxic than peptide 206- 
217. 
Various parts of the peptide molecule may be important 
to toxicity. It is suggested that certain amino acids may be 
responsible for binding to the enterocyte. Strongly basic 
ones such as arginine could be important in this respect. 
On the other hand, N-terminal proline peptides have, so 
far, not shown activity in any of the in vitro mucosal tissue 
assays. 
Key sequences of amino acids might act as antigenic 
172 H. Cornell, T. Mothes / Biochimica et Biophysica Acta 1270 (1995) 168-172 
determinants or inhibit digestion by peptidases. Many pep- 
tidases have preferences for peptide bonds formed by 
specific amino acids. Glutamine-, proline-, tyrosine- and 
serine- containing peptides have been detected in material 
remaining after in vitro digestion of fraction 9 with remis- 
sion coeliac mucosa [16]. 
Finally, there is the question of the mechanism of 
toxicity caused by the presence of peptides in abnormally 
high concentrations, caused by defective intestinal diges- 
tion. These peptides could have direct cytotoxic action on 
enterocytes and could trigger immunological reactions 
leading to mucosal damage. 
In summary, there appear to be several peptides derived 
from A-gliadin which are active in in vitro assays of 
toxicity in coeliac discase. Until now, active peptides that 
have been reported are comprised of at least 12 amino acid 
residues. Hence peptide VII, being a nonapeptide, repre- 
sents the smallest part of the A-gliadin molecule so far 
reported which is still very active. 
Deletion and substitution of amino acids in these active 
peptides should yield valuable information on the influ- 
ence of certain amino acids and the importance of key 
motifs. Such studies will no doubt pave the way for in vivo 
confirmation of toxicity of specific peptides, which is 
awaited eagerly. 
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